Very positive breakthrough in the coronavirus pandemic!

17.06.2020 | Maria Eugenia Moreno
Moreno

Maria Eugenia Moreno
Senior Consultant

We are happy to hear the good news on the studies of Dexamethasone for the treatment of COVID-19.

During this difficult time we at Diapharm are organizing audits at API manufacturers worldwide and have many reports available. Do you require API audits or audit reports? Contact us for audit reports on manufacturing of Dexamethasone API or any other API audits required: auditsNOSPAM@diapharm.com

Our Global Audit Solutions team at Diapharm are happy to be of help.
Stay safe!

#audits #gmp #api #auditreport #dexamethasone #staysafe

Weiterempfehlen:  
Aktuelles

 

Sprechen Sie uns an!

Unser Servicetelefon +49 251 609350 
+43 1 5321606 

Unsere E-Mail info@diapharm.com